Journal
CLINICAL CANCER RESEARCH
Volume 16, Issue 14, Pages 3754-3759Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-10-0439
Keywords
-
Categories
Funding
- Cancer Research UK [C348/A3758, C348/A8896]
- CORE Charity as part of the Digestive Cancer Campaign, Scottish Government Chief Scientist Office [K/OPR/2/2/D333, CZB/4/94]
- Medical Research Council [G0000657-53203]
- Cancer Research UK Fellowship [C31250/A10107]
- Cancer Research UK Clinician Scientist Fellowship [C26031/A11378]
- MRC [MC_U127527198] Funding Source: UKRI
- Cancer Research UK [11378] Funding Source: researchfish
- Chief Scientist Office [CZB/4/449] Funding Source: researchfish
- Medical Research Council [MC_U127527198] Funding Source: researchfish
Ask authors/readers for more resources
Purpose: To date, genomewide association studies have identified 10 genetic loci associated with colorectal cancer (CRC) susceptibility. We hypothesized that these loci might also affect cancer survival. Experimental Design: To determine whether single-nucleotide polymorphisms tagging these 10 loci influenced all-cause and CRC-specific mortality, we prospectively followed survival outcomes for 2,838 Scottish patients recruited soon after a diagnosis of CRC. Survival analysis was conducted using Cox proportional hazard models adjusted for American Joint Committee on Cancer stage, age, and sex. Results: None of the single-nucleotide polymorphisms were found to be statistically significantly associated with all-cause or CRC-specific mortality. Conclusions: We conclude that none of the 10 common genetic variants thus far shown to be associated with CRC risk are associated with survival from CRC. Clin Cancer Res; 16(14); 3754-9. (C)2010 AACR.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available